EP 1539117 A1 20050615 - FORMULATIONS OF FENOFIBRATE AND/OR FENOFIBRATE DERIVATIVES WITH IMPROVED ORAL BIOAVAILABILITY
Title (en)
FORMULATIONS OF FENOFIBRATE AND/OR FENOFIBRATE DERIVATIVES WITH IMPROVED ORAL BIOAVAILABILITY
Title (de)
FORMULIERUNGEN AUS FENOFIBRAT UND/ODER FENOFIBRAT-DERIVATEN MIT VERBESSERTER BIOVERF GBARKEIT
Title (fr)
FORMULATIONS A BASE DE FENOFIBRATE ET/OU DE DERIVES DE FENOFIBRATE AYANT UNE BIODISPONIBILITE ORALE AMELIOREE
Publication
Application
Priority
- US 0241093 W 20021220
- US 39280602 P 20020628
- US 39279102 P 20020628
Abstract (en)
[origin: WO2004002458A1] A fibrate oral formulation with improved bioavailability when compared to commercially available formulations containing a therapeutically effective dose of fenofibrate or a fenofibrate derivative dissolved in N-alkyl derivative of 2-pyrrolidone, ethylene glycol monoether, C8-12 fatty acid ester of polyethylene glycol, fatty acids, or combinations thereof useful for the treatment of hypercholesterolaemia or hypertriglyceridaemia in mammals.
IPC 1-7
IPC 8 full level
A61K 9/107 (2006.01); A61K 9/48 (2006.01); A61K 9/54 (2006.01); A61K 9/66 (2006.01); A61K 31/216 (2006.01)
CPC (source: EP)
A61K 9/1075 (2013.01); A61K 9/4858 (2013.01); A61K 31/216 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR
DOCDB simple family (publication)
WO 2004002458 A1 20040108; EP 1539117 A1 20050615; EP 1539117 A4 20051214
DOCDB simple family (application)
US 0241093 W 20021220; EP 02801215 A 20021220